	"myopathy, centronuclear, 2"	Charlevoix-Saguenay spastic ataxia	corpus callosum agenesis-intellectual disability-coloboma-micrognathia syndrome	normophosphatemic familial tumoral calcinosis	"neuronopathy, distal hereditary motor, type 2C"	Mirage syndrome; MIRAGE
protein phosphatase 2A binding	0.0	0.0	1.0	0.0	0.0	0.0
negative regulation of signal transduction	0.0	0.0	1.0	0.0	0.0	0.0
protein phosphatase regulator activity	0.0	0.0	1.0	0.0	0.0	0.0
regulation of signal transduction	0.0	0.0	1.0	0.0	0.0	0.0
TOR signaling	0.0	0.0	1.0	0.0	0.0	0.0
B cell activation	0.0	0.0	1.0	0.0	0.0	0.0
positive regulation of transcription from RNA polymerase I promoter	0.0	0.0	1.0	0.0	0.0	0.0
regulation of dephosphorylation	0.0	0.0	1.0	0.0	0.0	0.0
phosphatase regulator activity	0.0	0.0	1.0	0.0	0.0	0.0
